Alnylam Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

2,100

Employees2,100

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

2,100

Employees2,100

ALNY Key Statistics

Market cap

32.10B

Market cap32.10B

Price-Earnings ratio

-94.91

Price-Earnings ratio-94.91

Dividend yield

—

Dividend yield—

Average volume

996.39K

Average volume996.39K

High today

—

High today—

Low today

—

Low today—

Open price

$235.78

Open price$235.78

Volume

0.00

Volume0.00

52 Week high

$304.39

52 Week high$304.39

52 Week low

$141.98

52 Week low$141.98

ALNY News

TipRanks 4d

Alnylam Pharmaceuticals announces interim Phase 1 data of nucresiran

Alnylam (ALNY) Pharmaceuticals announced the presentation of new results from its Phase 1 study of nucresiran, a next-generation RNAi therapeutic in development...

Analyst ratings

70%

of 33 ratings

Buy

69.7%

Hold

24.2%

Sell

6.1%